Loading
Fast grants for oncology would be a fund that decides within two days on small grants for quick, decisive experiments in cancers or questions that mainstream funders neglect, modelled on the pandemic-era Fast Grants.
Fast Grants during COVID-19 funded hundreds of projects with 48-hour decisions and a one-page application; several delivered results, and recipients reported that speed, not just money, changed what they attempted. A cancer version would target neglected cancers and unfashionable questions (cachexia, metastasis models, surgical technique, repurposed drugs) with awards of $10,000 to $500,000, pre-registration of the key experiment, and a public results record including failures.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares The valley of death between lab and product, Funding follows fashion, not burden.
Shares The valley of death between lab and product, Funding follows fashion, not burden.